[144] Tectonic Therapeutic, Inc. SEC Filing

PETER MCNAMARA reported insider sales of Common stock under 10b5-1 plans.

Rhea-AI Filing Summary

PETER MCNAMARA reported insider sales of Common stock under 10b5-1 plans. The filing lists two 10b5-1 sale transactions: 1,650 shares on 03/04/2026 for $41,250.00 and 1,649 shares on 03/03/2026 for $36,376.94. The form also notes prior option exercises (3,547 and 2,715 shares with exercise dates shown).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 04:31 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002023255
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TECTONIC THERAPEUTIC, INC.
SEC File Number	001-38537
Address of Issuer	490 Arsenal Way Suite 200 Watertown MASSACHUSETTS 02472
Phone	339-666-3320
Name of Person for Whose Account the Securities are To Be Sold	PETER MCNAMARA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	6262	174396.70	18776626	03/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/06/2026	Exercise of Stock Options	Issuer			2715	03/06/2026	Cash
Common	06/26/2024	Previously Exercised Stock Options	Issuer			3547	06/26/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for PETER MCNAMARA 490 Arsenal Way Suite 200 Watertown MA 02472	Common	03/04/2026	1650	41250.00
10b5-1 Sales for PETER MCNAMARA 490 Arsenal Way Suite 200 Watertown MA 02472	Common	03/03/2026	1649	36376.94

144: Remarks and Signature

Remarks	The securities to be sold were acquired upon the exercise of stock options during the period of 06/26/2024 through 12/03/2024.
Date of Notice	03/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/14/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Peter McNamara
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)